Gallium citrate - Aridis PharmaceuticalsAlternative Names: Panaecin
Latest Information Update: 12 Jan 2017
At a glance
- Originator Aridis Pharmaceuticals
- Class Antibacterials; Citrates; Contrast media; Heavy metals; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules
- Mechanism of Action DNA synthesis inhibitors; Multienzyme complex inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Cystic fibrosis-associated respiratory tract infections